These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 15028260

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A new screening system for NAD(P)H:quinone oxidoreductase (NQO1)-directed antitumor quinones: identification of a new aziridinylbenzoquinone, RH1, as a NQO1-directed antitumor agent.
    Winski SL, Hargreaves RH, Butler J, Ross D.
    Clin Cancer Res; 1998 Dec; 4(12):3083-8. PubMed ID: 9865924
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Indolequinone antitumor agents: correlation between quinone structure and rate of metabolism by recombinant human NAD(P)H:quinone oxidoreductase. Part 2.
    Swann E, Barraja P, Oberlander AM, Gardipee WT, Hudnott AR, Beall HD, Moody CJ.
    J Med Chem; 2001 Sep 27; 44(20):3311-9. PubMed ID: 11563930
    [Abstract] [Full Text] [Related]

  • 9. Indolequinone antitumor agents: relationship between quinone structure and rate of metabolism by recombinant human NQO1.
    Beall HD, Hudnott AR, Winski S, Siegel D, Swann E, Ross D, Moody CJ.
    Bioorg Med Chem Lett; 1998 Mar 03; 8(5):545-8. PubMed ID: 9871615
    [Abstract] [Full Text] [Related]

  • 10. Lavendamycin antitumor agents: structure-based design, synthesis, and NAD(P)H:quinone oxidoreductase 1 (NQO1) model validation with molecular docking and biological studies.
    Hassani M, Cai W, Koelsch KH, Holley DC, Rose AS, Olang F, Lineswala JP, Holloway WG, Gerdes JM, Behforouz M, Beall HD.
    J Med Chem; 2008 Jun 12; 51(11):3104-15. PubMed ID: 18457384
    [Abstract] [Full Text] [Related]

  • 11. COMPARE analysis of the toxicity of an iminoquinone derivative of the imidazo[5,4-f]benzimidazoles with NAD(P)H:quinone oxidoreductase 1 (NQO1) activity and computational docking of quinones as NQO1 substrates.
    Fagan V, Bonham S, Carty MP, Saenz-Méndez P, Eriksson LA, Aldabbagh F.
    Bioorg Med Chem; 2012 May 15; 20(10):3223-32. PubMed ID: 22522008
    [Abstract] [Full Text] [Related]

  • 12. Benzimidazole- and benzothiazole-quinones: excellent substrates for NAD(P)H:quinone oxidoreductase 1.
    Newsome JJ, Colucci MA, Hassani M, Beall HD, Moody CJ.
    Org Biomol Chem; 2007 Nov 21; 5(22):3665-73. PubMed ID: 17971996
    [Abstract] [Full Text] [Related]

  • 13. 2-Substituted 3-methylnaphtho[1,2-b]furan-4,5-diones as novel L-shaped ortho-quinone substrates for NAD(P)H:quinone oxidoreductase (NQO1).
    Bian J, Deng B, Xu L, Xu X, Wang N, Hu T, Yao Z, Du J, Yang L, Lei Y, Li X, Sun H, Zhang X, You Q.
    Eur J Med Chem; 2014 Jul 23; 82():56-67. PubMed ID: 24874653
    [Abstract] [Full Text] [Related]

  • 14. Studies on quinones. Part 42: Synthesis of furylquinone and hydroquinones with antiproliferative activity against human tumor cell lines.
    Benites J, Valderrama JA, Rivera F, Rojo L, Campos N, Pedro M, José Nascimento MS.
    Bioorg Med Chem; 2008 Jan 15; 16(2):862-8. PubMed ID: 17964791
    [Abstract] [Full Text] [Related]

  • 15. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
    Fourie J, Oleschuk CJ, Guziec F, Guziec L, Fiterman DJ, Monterrosa C, Begleiter A.
    Cancer Chemother Pharmacol; 2002 Feb 15; 49(2):101-10. PubMed ID: 11862423
    [Abstract] [Full Text] [Related]

  • 16. Studies on quinones. Part 45: novel 7-aminoisoquinoline-5,8-quinone derivatives with antitumor properties on cancer cell lines.
    Valderrama JA, Ibacache JA, Arancibia V, Rodriguez J, Theoduloz C.
    Bioorg Med Chem; 2009 Apr 01; 17(7):2894-901. PubMed ID: 19269832
    [Abstract] [Full Text] [Related]

  • 17. Bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) by human NAD(P)H quinone oxidoreductase 2: a novel co-substrate-mediated antitumor prodrug therapy.
    Knox RJ, Jenkins TC, Hobbs SM, Chen S, Melton RG, Burke PJ.
    Cancer Res; 2000 Aug 01; 60(15):4179-86. PubMed ID: 10945627
    [Abstract] [Full Text] [Related]

  • 18. Cross-linking and sequence-specific alkylation of DNA by aziridinylquinones. 3. Effects of alkyl substituents.
    Hargreaves RH, O'Hare CC, Hartley JA, Ross D, Butler J.
    J Med Chem; 1999 Jun 17; 42(12):2245-50. PubMed ID: 10377230
    [Abstract] [Full Text] [Related]

  • 19. Betulin-1,4-quinone hybrids: Synthesis, anticancer activity and molecular docking study with NQO1 enzyme.
    Kadela-Tomanek M, Bębenek E, Chrobak E, Marciniec K, Latocha M, Kuśmierz D, Jastrzębska M, Boryczka S.
    Eur J Med Chem; 2019 Sep 01; 177():302-315. PubMed ID: 31158746
    [Abstract] [Full Text] [Related]

  • 20. Novel quinolinequinone antitumor agents: structure-metabolism studies with NAD(P)H:quinone oxidoreductase (NQO1).
    Fryatt T, Goroski DT, Nilson ZD, Moody CJ, Beall HD.
    Bioorg Med Chem Lett; 1999 Aug 02; 9(15):2195-8. PubMed ID: 10465544
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.